UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review

Drug discovery today, 2019-01, Vol.24 (1), p.57-68

2019

Volltextzugriff (PDF)

Belgian population norms for the EQ-5D-5L, 2018

Quality of life research, 2022-02, Vol.31 (2), p.527-537

2022

Volltextzugriff (PDF)

Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study

Frontiers in pharmacology, 2019, Vol.10 (1395), p.1395-1395

2019

Volltextzugriff (PDF)

Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review

BMC medical informatics and decision making, 2019-10, Vol.19 (1), p.189-189, Article 189

2019

Volltextzugriff (PDF)

A comparative study of European rare disease and orphan drug markets

Health policy (Amsterdam), 2010-10, Vol.97 (2), p.173-179

2010

Volltextzugriff (PDF)

Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy: A Delphi Survey in Belgian Stakeholders

Value in health, 2015-06, Vol.18 (4), p.477-483

2015

Volltextzugriff (PDF)

Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients : a literature review

Transplant international, 2005-10, Vol.18 (10), p.1121-1133

2005

Volltextzugriff (PDF)

How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action

Frontiers in pharmacology, 2023, Vol.14, p.1192770-1192770

2023

Volltextzugriff (PDF)

Patients as research partners in preference studies: learnings from IMI-PREFER

Research involvement and engagement, 2023-04, Vol.9 (1), p.21-21, Article 21

2023

Volltextzugriff (PDF)

Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA

The patient : patient-centered outcomes research, 2019-10, Vol.12 (5), p.513-526

2019

Volltextzugriff (PDF)

Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US

Frontiers in pharmacology, 2019, Vol.10, p.1009-1009

2019

Volltextzugriff (PDF)

What Does the Public Want? Structural Consideration of Citizen Preferences in Health Care Coverage Decisions

MDM policy & practice, 2018-07, Vol.3 (2), p.2381468318799628-2381468318799628

2018

Volltextzugriff (PDF)

Economic implications of non-compliance in health care

The Lancet (British edition), 2002-06, Vol.359 (9324), p.2129-2130

2002

Volltextzugriff (PDF)

Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests

Value in health, 2009-06, Vol.12 (4), p.441-449

2009

Volltextzugriff (PDF)

A social preference valuations set for EQ-5D health states in Flanders, Belgium

The European journal of health economics, 2010-04, Vol.11 (2), p.205-213

Cleemput, Irina

2010

Volltextzugriff (PDF)

Barriers and facilitators related to the implementation of surgical safety checklists: a systematic review of the qualitative evidence

BMJ Quality & Safety, 2015-12, Vol.24 (12), p.776-786

2015

Volltextzugriff (PDF)

A review of the literature on the economics of noncompliance. Room for methodological improvement

Health policy (Amsterdam), 2002, Vol.59 (1), p.65-94

2002

Volltextzugriff (PDF)

An EQ-5D-5L Value Set for Belgium

PharmacoEconomics - open, 2022-11, Vol.6 (6), p.823-836

2022

Volltextzugriff (PDF)

Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment Guidelines

PharmacoEconomics, 2018-02, Vol.36 (2), p.127-130

2018

Volltextzugriff (PDF)

WHICH QUALITY OF LIFE MEASURES FIT YOUR RELATIVE EFFECTIVENESS ASSESSMENT?

International journal of technology assessment in health care, 2015-01, Vol.31 (3), p.147-153

2015

Volltextzugriff (PDF)

Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward

Value in health, 2019-11, Vol.22 (11), p.1283-1288

2019

Volltextzugriff (PDF)

Measuring patient-reported outcomes in solid organ transplant recipients : An overview of instruments developed to date

PharmacoEconomics, 2007-01, Vol.25 (4), p.269-286

2007

Volltextzugriff (PDF)

An evaluation of managed entry agreements in Belgium: A system with threats and (high) potential if properly applied

Health policy (Amsterdam), 2020-09, Vol.124 (9), p.959-964

2020

Volltextzugriff (PDF)

A multi-criteria decision approach for ranking unmet needs in healthcare

Health policy (Amsterdam), 2018-08, Vol.122 (8), p.878-884

2018

Volltextzugriff (PDF)

Gender and educational differences in the association between smoking and health-related quality of life in Belgium

Preventive medicine, 2017-12, Vol.105, p.280-286

2017

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(83)
Buchkapitel
(1)

Sprache

Englisch
(79)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(68)
Science & Technology
(68)
Humans
(54)
Health Care Sciences & Services
(48)
Health Policy & Services
(27)
Health Technology Assessment
(24)
Belgium
(22)
Public, Environmental & Occupational Health
(22)
Decision Making
(20)
Medical Informatics
(20)
Reimbursement
(19)
Patients
(18)
Health Care
(17)
Europe
(15)
Health Administration
(15)
Economics
(14)
Business & Economics
(13)
Pharmacology & Pharmacy
(13)
Social Sciences
(13)
Technology Assessment
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review

Belgian population norms for the EQ-5D-5L, 2018

Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study

Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review

A comparative study of European rare disease and orphan drug markets

Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy: A Delphi Survey in Belgian Stakeholders

Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients : a literature review

How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action

Patients as research partners in preference studies: learnings from IMI-PREFER

Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA

Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US

What Does the Public Want? Structural Consideration of Citizen Preferences in Health Care Coverage Decisions

Economic implications of non-compliance in health care

Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests

A social preference valuations set for EQ-5D health states in Flanders, Belgium

Barriers and facilitators related to the implementation of surgical safety checklists: a systematic review of the qualitative evidence

A review of the literature on the economics of noncompliance. Room for methodological improvement

An EQ-5D-5L Value Set for Belgium

Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment Guidelines

WHICH QUALITY OF LIFE MEASURES FIT YOUR RELATIVE EFFECTIVENESS ASSESSMENT?

Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward

Measuring patient-reported outcomes in solid organ transplant recipients : An overview of instruments developed to date

An evaluation of managed entry agreements in Belgium: A system with threats and (high) potential if properly applied

A multi-criteria decision approach for ranking unmet needs in healthcare

Gender and educational differences in the association between smoking and health-related quality of life in Belgium

Suchergebnisse filtern